A company that provides a metabolic approach to sustainable weight loss.

Calibrate

Calibrate is on a mission to change the way the world treats weight. As the leading clinician-guided and value-based outcomes model in obesity treatment, Calibrate combines medication with transformative behavior change to improve overall metabolic health, driving cost-effective, long-term weight loss results while reducing the total cost of care for employers and payers. 

Recognized by esteemed organizations, including the World Economic Forum’s Technology Pioneers, Fast Company’s World Changing Ideas, TIME’s Best Inventions, and the Employer Health Innovation Roundtable Traction Awards. Calibrate is backed by leading healthcare investors, including Madryn Asset Management, and Redesign Health.

Madryn Asset Management

What If Ventures

Samsung NEXT

SMVentures

Forerunner Ventures

Redesign Health

Steph Korey Goodwin

Threshold

Optum Ventures

Tiger Global Management

Founders Fund

The goal is clear - sustainable health through informed choices and continuous support! 

Explore our latest blog, "Decoding GLP-1 Tapering: A Strategic Approach to Sustainable Health," by Kristin Baier MD, VP of Clinical Development, where she delves into the nuances of GLP-1 tapering, a precise approach designed to sustain metabolic health and obesity treatment.

Key Highlights Include:
- Who Benefits? Understand the criteria for tapering and the collaborative decision-making process between clinicians and members.
- Potential Outcomes: Learn about dosage adjustments and the potential transition to other medications.
- Evidence-Based: Backed by the latest research and expert opinions, our approach integrates medication with lifestyle modifications for lasting health benefits.

Read the full article for a deeper dive into GLP-1 tapering strategies and their clinical implications. https://lnkd.in/e2VDSpRB

#HealthcareInnovation #ClinicalExcellence #GLP1 #MetabolicHealth #ObesityTreatment

Hate running?

It's okay if you do! Walking offers tremendous benefits and it's one of my favorite ways to ease patients into an exercise regimen.

The timing of your walk can have an impact too. For example, walking for 10-15 minutes after a meal improves postprandial glucose, reduces HbA1c and glycated albumin. One study showed that patients with Type 2 Diabetes had better glucose control with a 10 minute postprandial walk compared to a 30 minute daily walk. 

I'm happy to have contributed to this article on the benefits of walking by Natasha Burton and the Lose It! team. https://lnkd.in/gbmxUtNC

Worried about the impact of GLP-1 shortages on your employees? 

Calibrate has shown that medication is a tool—not the entire treatment. Our comprehensive lifestyle intervention empowers members to achieve sustainable weight loss—with or without continuous medication, and we have the data to back it up. 

Calibrate recently conducted a real-world analysis of medication access and clinical outcomes for obesity treatment with GLP-1s. This analysis, presented at the Endocrine Society, reveals that even with significant gaps in medication access, Calibrate members achieved clinically significant weight loss outcomes. 

Key Findings: 
- Members who did not experience a 13-week medication disruption over 24 months achieved an average weight loss of 17.28% at their 12-month mark. 
- Members who experienced a medication disruption of at least 13 weeks over the same period still saw an impressive average weight loss of 14.96%

Whether on a GLP-1 or not, Calibrate members lose weight—and keep it off, for good. 

To read more about our findings, check out our poster: https://lnkd.in/eC_wHCCW

#HolisticApproach #GLP1s #ClinicalOutcomes

It was absolutely delightful spending time with my brilliant colleague Jess Brown  at The Healthcare Innovation Company (thINc) Congress in collaboration with Validation Institute. Tremendous and actionable insights we will center as we innovate at Calibrate   #FoodIsMedicine #ObesityManagement #HealthEquity #LeadingWithValues

🩺 As National Nurses Week kicks off, we want to recognize our remarkable team of nurses at Calibrate who embody our values of providing high-quality, compassionate obesity care. Your empathy, expertise, and unwavering dedication are the driving force behind the success of our members. 

At Calibrate, our nurses are the backbone of our comprehensive and personalized clinical support. Day in and day out, they go above and beyond to deliver real results, helping our members achieve an average weight loss of 18% over two years.

💜 Not only to our Calibrate nurses, but to nurses everywhere: we are profoundly grateful for your impact, contributions, and sacrifices. Please join us in honoring and celebrating these healthcare heroes who make a difference in the lives of so many.

Below, you’ll find a few of our phenomenal Calibrate nurses along with their Why for choosing the profession. Check it out below ⬇️

#NationalNursesWeek #ThankYouNurses #HealthcareHeroes

"In patients treated with semaglutide, weight loss continued over 65 weeks and was sustained for up to 4 years." 

In addition to what appears to be cardiovascular protective effects from semaglutide before weigh loss even occurs, it's incredibly exciting to see these results as we know the recidivism rate in weight loss is extremely high. It also highlights the importance of combining GLP medication with intensive lifestyle interventions for optimal outcomes. This SELECT trial had a lower average weight loss (mean 10.2% at 208 weeks) than the STEP trials (mean 14.9% at 68 weeks) which is likely due to the lifestyle interventions (caloric restriction and exercises) that were required of the participants in STEP.  As the pioneer of comprehensive obesity treatment, Calibrate continues to expand access to obesity care through our commercial program. Our proven results combine our lifestyle intervention, accountability coaching, and medication as a tool, not the entire treatment, as part of a larger, comprehensive approach to weight management to ensure that the right members are getting the right treatments at the right time for sustainable results.

news impact assignment basic	general
public peers	general	Jul 11, 2024 3:55 PM	48bd3906
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 11, 2024 10:30 AM	26ff60d3
crunchbase profile	general
li profile	general	Jul 11, 2024 3:55 PM	91ddde10
translate crunchbase fundingrounds	general
peers	general	Jul 11, 2024 3:55 PM	058ba947
news basic	general	Jul 11, 2024 3:55 PM	261fef2a
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:JOINCALIBRATE

Calibrate